At least $65,885 in Medicaid spending was recorded for COVID-19-related services in Allen Park in 2024, based on HCPCS codes earmarked for the virus, according to the U.S. Department of Health and Human Services Medicaid Provider Spending database.
Medicaid, operated by the states and financed in partnership by federal and state governments, provides health coverage for low-income residents, the elderly, children, and people with disabilities, positioning it among the main components of the U.S. health care system.
Taxpayer funding supports Medicaid, so fluctuations in billing locally can indicate shifts in how community health care resources are allocated.
This review identified COVID-19–related services by matching HCPCS codes that referenced “COVID-19” or “coronavirus” in billing details. As such, these numbers reflect only services directly marked as COVID-specific and may not include care billed under broader or different codes connected to the pandemic.
Detroit topped the list for COVID-19-related Medicaid payments in Michigan in 2024, with $432,564 in claims tied to virus care.
Six health care providers in Allen Park billed Medicaid for COVID-19-related services in 2024. The Immunoassay code stood out, accounting for $48,827 alone.
The average Medicaid reimbursement per provider in Allen Park for such services was $10,981, slightly below Michigan’s average of $11,005.
COVID-19 services drove a significant portion of Medicaid spending growth in Allen Park during the pandemic-era years.
According to the Centers for Medicare & Medicaid Services, combined federal and state Medicaid expenses rose to around $871.7 billion for fiscal year 2023, representing about 18% of total U.S. health spending, up from roughly $613.5 billion in 2019, prior to the onset of COVID-19.
This increase amounts to nearly 40% in a short span, mainly attributed to expanded program enrollment and increased use of services throughout and following the pandemic period.
Recent federal legislation under the Trump administration has included major policy shifts aiming to reduce federal Medicaid funding and alter the structure of the program. The “One Big Beautiful Bill Act,” which became law in 2025, is forecasted to trim more than $1 trillion from federal Medicaid outlays over the next 10 years and introduces requirements such as mandatory work participation and higher cost-sharing, potentially impacting coverage and funding for certain beneficiaries. These changes could transfer more financial responsibility to the states and restrict federal Medicaid growth even as enrollment continues to be significant.
| Year | COVID-19–Related Payments | COVID-19 Payments % Change (YoY) | Total Medicaid Payments |
|---|---|---|---|
| 2024 | $65,885 | -88.1% | $4,364,032 |
| 2023 | $553,901 | -65.8% | $5,276,995 |
| 2022 | $1,618,725 | 2.4% | $7,175,611 |
| 2021 | $1,581,070 | 465.7% | $7,746,561 |
| 2020 | $279,488 | N/A | $5,014,160 |
| 2019 | $0 | N/A | $4,035,646 |
| 2018 | $0 | N/A | $59,868,240 |
| HCPCS Code | Description | Medicaid Payments | Claims |
|---|---|---|---|
| 87811 | Immunoassay | $48,827 | 1,603 |
| U0002 | COVID Specific | $11,772 | 284 |
| 87635 | COVID Specific | $5,286 | 138 |
Note: Includes only HCPCS codes plainly designated for COVID-19 services; figures do not capture all health care expenditures related to the pandemic.
This article uses data collected from the U.S. Department of Health and Human Services Medicaid Provider Spending database. Find the source data here.
